Events
ESMO 2025: New generation of antibody-drug conjugates shows promise in early-stage disease
- ESMO 2025: Novel treatment combination improves progression-free survival in metastatic, oestrogen-receptor-positive HER-2-negative breast cancer
- NCCN Guidelines Navigator for breast cancer genetic testing and treatment
- Could reducing inflammation help combat fatigue in people with early-stage breast cancer?
The OJC 56: Is Food the Future of Cancer Treatment?
The Oncology Journal Club Episode 56: Is food the future of cancer treatment? Is the future of cancer treatment food?…
Wear and tear from lifelong stress can increase cancer mortality
The wear and tear on the body from chronic and lifelong stress can also lead to an increased risk of…








